Aura Biosciences, Inc. (AURA) Free cash flow 2020–2025
Aura Biosciences, Inc. (AURA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$85.2MFY2025 · since FY2020: -$25.1M → -$85.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$85.2M | -5.1% |
| FY2024 | -$81.1M | -25.6% |
| FY2023 | -$64.6M | -15.9% |
| FY2022 | -$55.7M | -61.3% |
| FY2021 | -$34.5M | -37.6% |
| FY2020 | -$25.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More AURA financial trends
AURA RevenueAURA Net incomeAURA Net marginAURA Gross profitAURA Gross marginAURA Operating incomeAURA Operating marginAURA Operating cash flowAURA Capital expendituresAURA Return on equityAURA Stock buybacksAURA Dividends paidAURA Total assetsAURA Total liabilitiesAURA Shareholders’ equityAURA overview →